MedTechIndexBETA
The MedTechIndex Briefing

Keep up with MedTechIndex.

A weekly note from Blair, new companies added to the directory, and meaningful updates to existing profiles.

Confirm your email to join. Email privacy

Companies / Sonendo
Medical device company profile

Sonendo

Dental technology manufacturer developing the GentleWave platform for root canal preparation, cleaning and irrigation.

Medical Device Manufacturer and DeveloperDental & Oral HealthEndodonticsCommercial-stage
HeadquartersπŸ‡ΊπŸ‡ΈLaguna Hills, California, United States
Founded2006
Commercial statusCommercially availableGentleWave root canal treatment platform and procedure consumables.
Employees51–200LinkedIn company-size range
Annual revenueUS$28.6 millionFY2025 Β· Preliminary, unaudited Β· Reported
Disclosed fundingUS$5 millionGross proceeds from private placement Β· May 2025
Official websitesonendo.com β†—Official careers β†—

Company overview

Sonendo is a Laguna Hills, California dental technology company led by President and CEO Bjarne Bergheim. Its core business is the GentleWave platform, which combines a reusable console with procedure-specific instruments and fluids for root canal treatment.

GentleWave uses fluid optimization, acoustic energy and fluid dynamics to clean and irrigate the root canal system. The current G4 platform includes ProControl software. In 2026 Sonendo also introduced FlowLogic endodontic files through a collaboration granting it North American sales rights to products from a European dental company.

Sonendo reported preliminary, unaudited revenue of US$28.6 million for 2025, with US$23.4 million from recurring procedure-related consumables and services. In September 2026 it reported that more than two million patients had received a GentleWave procedure since market introduction.

[1][2][3][4][5][18]

Leadership

5 people
Bjarne BergheimPresident & Chief Executive Officer [2]
Chris GuoChief Financial Officer & Vice President of Business Development [2]
John P. McGaughChief Operating Officer [2]
Robert Mac GuyattSenior Vice President, Commercial [2]
Kevin YeinVice President, Product Development [2]

Products & regulatory status How does MedTechIndex get this information?

Summary

FDA records document multiple GentleWave system clearances, including K190359 for the GentleWave System and K203302 for GentleWave X. K203302 covers preparation, cleaning and irrigation of teeth indicated for root canal therapy, with the permitted tooth types dependent on the procedure instrument. The current G4 branding is presented as part of the manufacturer’s GentleWave family; older clearance names are retained in the underlying records. [8][13][7][6][11][14][12][9][10][16][17][15][1][3]

Two Class II recall records initiated October 14, 2022 concern erroneous outer-carton labels on specified lots of APM Procedure Instruments (GW-APM-PI02, lot W2022080941R) and Posterior CleanFlow Procedure Instruments (GW-PST-PI01, lot W2022080204R). FDA lists both records as open/classified. The notice stated that the products and inner pouch labels were unaffected and requested customer acknowledgement. [8][13][7][6][11][14][12][9][10][16][17][15][1][3]

A separate foot-pedal recall, initiated October 23, 2019, concerned continued console operation after the pedal was released. Customers were instructed to replace and return the affected pedal. FDA lists that recall as terminated January 20, 2022. These records identify specific instruments, lots and an earlier console accessory; they do not establish a recall of every current G4 configuration. [8][13][7][6][11][14][12][9][10][16][17][15][1][3]

Regulatory snapshot How to read this snapshot

U.S. FDA
2+
510(k) clearances
β€”
De Novo grants
β€”
PMA approvals
β€”
Recall events

Latest recorded source review: 2026-11-06.

Scope: selected product families.

View 1 documented open recall event
Documented open FDA recall events
Recalled product / recordInitiatedSource
  • GentleWave System APM Procedure Instrument with Matrix REF GW-APM-PI02Z-0233-2023
  • GentleWave System Posterior CleanFlow Procedure Instrument with Matrices (Single) REF GW-PST-PI01Z-0234-2023
October 14, 2022[16][17]

Commercial portfolio snapshot

Documented commercial product families.

Sonendo GentleWave platform β€” official product image
Image: Sonendo
Root canal preparation, cleaning and irrigation system

GentleWave platform β†—

Console-based endodontic platform using optimized procedure fluid, acoustic energy and fluid dynamics with procedure-specific instruments. Sonendo currently markets the G4 system with ProControl software; FDA records also document earlier GentleWave configurations. [3][13][12]

Commercially available Β· FDA-cleared GentleWave family

Activity & Milestones

5 events
2026-09-22 Β· Commercial

Two-million-patient milestone reported

Sonendo reported more than two million patients treated with GentleWave since market introduction. [4]

2026-03-16 Β· Financial

Preliminary 2025 financial results reported

Sonendo reported US$28.6 million in preliminary, unaudited revenue for 2025 and described its FlowLogic file launch. [5]

2025-05-01 Β· Funding

US$5 million private placement disclosed

Sonendo disclosed US$5 million in gross proceeds from a private placement involving new and existing investors. [4]

2021-02-05 Β· Regulatory

GentleWave X receives FDA clearance

FDA cleared GentleWave X under K203302 for specified root canal preparation, cleaning and irrigation uses. [13]

2006 Β· Corporate

Company founded

Sonendo’s company profile records its founding in 2006. [18]

18 Cited Sources

Accessed 11/06/2026

[6] FDA 510(k) K130025 β€” SONENDO ENDOTHERAPY SYSTEM β†—U.S. Food and Drug Administration Β· regulator Β· Published 2013-06-11
[8] FDA 510(k) K143448 β€” Sonendo GentleWave System β†—U.S. Food and Drug Administration Β· regulator Β· Published 2015-05-01
[9] FDA 510(k) K153157 β€” Sonendo Gentle Wave System β†—U.S. Food and Drug Administration Β· regulator Β· Published 2016-01-29
[10] FDA 510(k) K160905 β€” Sonendo GentleWave System β†—U.S. Food and Drug Administration Β· regulator Β· Published 2016-06-03
[11] FDA 510(k) K181922 β€” Sonendo Material A β†—U.S. Food and Drug Administration Β· regulator Β· Published 2018-10-22
[12] FDA 510(k) K190359 β€” Sonendo GentleWave System β†—U.S. Food and Drug Administration Β· regulator Β· Published 2019-03-16
[13] FDA 510(k) K203302 β€” GentleWave X β†—U.S. Food and Drug Administration Β· regulator Β· Published 2021-02-05
[14] FDA 510(k) K211995 β€” Sonendo Filling Material 5C β†—U.S. Food and Drug Administration Β· regulator Β· Published 2021-08-27
[15] FDA recall Z-2162-2020 β€” GENTLEWAVE REF: FG-002-0001 β†—U.S. Food and Drug Administration Β· regulator
[18] Sonendo β€” company details β†—Sonendo / LinkedIn Β· other
Company research

Compare companies

Privacy choices

Your saved-company and comparison preferences are stored separately. Changing analytics preferences does not clear them.

About cookies and privacy